JLab Hear OTC vs Lexie B3

The JLab Hear OTC is a budget-friendly OTC hearing aid priced at $100, earning a B grade with a SoundScore of 3.6/5 in HearAdvisor's lab testing. This visible-in-ear device ranks #36 of 65 OTC hearing aids tested, placing it in the top 54% of its category. In our testing, the JLab Hear OTC shows a distinctive performance profile with clear strengths and weaknesses. Music streaming stands out as exceptional, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling also performs excellently at 5.0/5, providing stable amplification without whistling during our standardized challenge motions. These strengths make it particularly well-suited for users who prioritize streaming audio content. However, speech performance presents limitations. Speech in quiet scores 2.1/5, which is 0.67 points below the category average of 2.79. Speech in noise is more constrained at 1.0/5, falling 0.46 points below average. Own-voice comfort also scores low at 1.8/5, which is 0.71 points below the category norm. These results suggest the device may be less effective for primary speech amplification needs compared to alternatives in its price range. The JLab Hear OTC includes rechargeable batteries and supports both iPhone and Android streaming with hands-free functionality. At this price point, competitors like the Elehear Beyond (4.36/5) and Apple AirPods Pro 2 (4.06/5) offer stronger overall sound performance. This device may appeal most to budget-conscious users who value excellent streaming quality and feedback stability over speech enhancement capabilities.

The Lexie B3 is a behind-the-ear OTC hearing aid priced at $999 that earns an A grade with a SoundScore of 4.8/5 in our lab testing. This places it at #1 among the 65 OTC hearing aids we've evaluated, making it a standout performer in its category. In our standardized testing, the Lexie B3 demonstrates excellent speech-in-quiet performance at 4.5/5, scoring 1.73 points above the OTC category average of 2.79/5. Speech-in-noise results are more nuanced—while the 2.5/5 score sits 1.02 points above the category average of 1.48/5, this remains mixed in absolute terms. Music streaming quality is solid at 3.3/5, exceeding the category average by 1.38 points, and feedback handling is excellent at 4.6/5. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above the category average. The device uses a tulip dome coupling in both initial and tuned configurations, maintaining consistent performance across fitting conditions with identical normalized scores of 4.8/5 for both fits. For those considering alternatives, devices like the RxEars Rxi, Meta Ray-Ban Glasses (Gen 2), and Cearvol Wave offer lower price points, though with correspondingly lower SoundScores. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance who prioritize speech clarity in quieter environments and quality music streaming, and who can accommodate its mid-tier OTC price point.